theophylline has been researched along with lubiprostone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bindslev, N; Hansen, MB; Kaltoft, N; Osbak, PS; Poulsen, SS; Tilotta, MC; Witte, AB | 1 |
1 review(s) available for theophylline and lubiprostone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for theophylline and lubiprostone
Article | Year |
---|---|
Prostaglandin E2-induced colonic secretion in patients with and without colorectal neoplasia.
Topics: Alprostadil; Biopsy; Bumetanide; Colforsin; Colon; Colorectal Neoplasms; Dinoprostone; Female; Humans; Ion Transport; Lubiprostone; Male; Middle Aged; Ouabain; Prostaglandin-Endoperoxide Synthases; Receptors, Prostaglandin E; Reference Values; Signal Transduction; Tamoxifen; Theophylline | 2010 |